315 related articles for article (PubMed ID: 33961921)
21. Comparing Mohs micrographic surgery and wide local excision in the management of head and neck dermatofibrosarcoma protuberans: a scoping review.
Sanabria A; Pinillos P; Chiesa-Estomba C; Guntinas-Lichius O; Kowalski LP; Mäkitie AA; Rao KN; Ferlito A
J Dermatolog Treat; 2024 Dec; 35(1):2295816. PubMed ID: 38146660
[TBL] [Abstract][Full Text] [Related]
22. Melanomas of the head and neck have high-local recurrence risk features and require tissue-rearranging reconstruction more commonly than basal cell carcinoma and squamous cell carcinoma: A comparison of indications for microscopic margin control prior to reconstruction in 13,664 tumors.
Fix W; Etzkorn JR; Shin TM; Howe N; Bhatt M; Sobanko JF; Miller CJ
J Am Acad Dermatol; 2021 Aug; 85(2):409-418. PubMed ID: 30458206
[TBL] [Abstract][Full Text] [Related]
23. Dermatofibrosarcoma Protuberans Recurrence After Wide Local Excision Versus Mohs Micrographic Surgery: A Systematic Review and Meta-Analysis.
Martin ECS; Vyas KS; Batbold S; Erwin PJ; Brewer JD
Dermatol Surg; 2022 May; 48(5):479-485. PubMed ID: 35353755
[TBL] [Abstract][Full Text] [Related]
24. Recurrence rates of cutaneous squamous cell carcinoma of the head and neck after Mohs micrographic surgery vs. standard excision: a retrospective cohort study.
van Lee CB; Roorda BM; Wakkee M; Voorham Q; Mooyaart AL; de Vijlder HC; Nijsten T; van den Bos RR
Br J Dermatol; 2019 Aug; 181(2):338-343. PubMed ID: 30199574
[TBL] [Abstract][Full Text] [Related]
25. Mohs micrographic surgery for the treatment of primary cutaneous melanoma.
Zitelli JA; Brown C; Hanusa BH
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 1):236-45. PubMed ID: 9270510
[TBL] [Abstract][Full Text] [Related]
26. Mohs Micrographic Surgery for the Treatment of Cutaneous Melanomas of the Head and Neck.
Jacobsen ES; Soleymani T
Oral Maxillofac Surg Clin North Am; 2022 May; 34(2):263-271. PubMed ID: 35428505
[TBL] [Abstract][Full Text] [Related]
27. Comparison of outcomes for malignant melanoma of the face treated using Mohs micrographic surgery and wide local excision.
Chin-Lenn L; Murynka T; McKinnon JG; Arlette JP
Dermatol Surg; 2013 Nov; 39(11):1637-45. PubMed ID: 24164702
[TBL] [Abstract][Full Text] [Related]
28. Differences in sentinel lymph node biopsy utilization in eligible melanoma patients treated with Mohs micrographic surgery or wide local excision: A population-based logistic regression model and survival analysis.
Knackstedt TJ
J Am Acad Dermatol; 2023 Apr; 88(4):848-855. PubMed ID: 36368376
[TBL] [Abstract][Full Text] [Related]
29. Recurrence Rate for Melanoma Excised by Mohs Micrographic Surgery Without Immunostaining.
Vieira C; Jennings T; Renzi MA; Lawrence N; Decker A
Dermatol Surg; 2022 May; 48(5):492-497. PubMed ID: 35298442
[TBL] [Abstract][Full Text] [Related]
30. Mohs micrographic surgery versus wide local excision for eyelid melanoma: An analysis of a national database.
Ramachandran V; Phan K
J Plast Reconstr Aesthet Surg; 2022 Dec; 75(12):4410-4415. PubMed ID: 36257889
[TBL] [Abstract][Full Text] [Related]
31. The use of Mohs micrographic surgery (MMS) for melanoma in situ (MIS) of the trunk and proximal extremities.
Stigall LE; Brodland DG; Zitelli JA
J Am Acad Dermatol; 2016 Nov; 75(5):1015-1021. PubMed ID: 27473456
[TBL] [Abstract][Full Text] [Related]
32. Time to recurrence after surgical excision of atypical fibroxanthoma-updated systematic review and meta-analysis.
Phan K; Onggo J
Australas J Dermatol; 2019 Aug; 60(3):e220-e222. PubMed ID: 30793288
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcomes of Mohs micrographic surgery for invasive melanoma of the trunk and proximal portion of the extremities.
Burnett ME; Brodland DG; Zitelli JA
J Am Acad Dermatol; 2021 Mar; 84(3):661-668. PubMed ID: 32763327
[TBL] [Abstract][Full Text] [Related]
34. Outcomes for Invasive Melanomas Treated With Mohs Micrographic Surgery: A Retrospective Cohort Study.
Degesys CA; Powell HB; Hsia LB; Merritt BG
Dermatol Surg; 2019 Feb; 45(2):223-228. PubMed ID: 30199430
[TBL] [Abstract][Full Text] [Related]
35. Outcomes in intermediate-risk squamous cell carcinomas treated with Mohs micrographic surgery compared with wide local excision.
Xiong DD; Beal BT; Varra V; Rodriguez M; Cundall H; Woody NM; Vidimos AT; Koyfman SA; Knackstedt TJ
J Am Acad Dermatol; 2020 May; 82(5):1195-1204. PubMed ID: 31887322
[TBL] [Abstract][Full Text] [Related]
36. Mohs surgery for the treatment of lentigo maligna and lentigo maligna melanoma - a systematic review.
Sharma AN; Foulad DP; Doan L; Lee PK; Atanaskova Mesinkovska N
J Dermatolog Treat; 2021 Mar; 32(2):157-163. PubMed ID: 31696746
[TBL] [Abstract][Full Text] [Related]
37. Mohs micrographic surgery for melanoma: A prospective multicenter study.
Ellison PM; Zitelli JA; Brodland DG
J Am Acad Dermatol; 2019 Sep; 81(3):767-774. PubMed ID: 31150700
[TBL] [Abstract][Full Text] [Related]
38. Mohs Micrographic Surgery Using MART-1 Immunostain in the Treatment of Invasive Melanoma and Melanoma In Situ.
Valentín-Nogueras SM; Brodland DG; Zitelli JA; González-Sepúlveda L; Nazario CM
Dermatol Surg; 2016 Jun; 42(6):733-44. PubMed ID: 27158886
[TBL] [Abstract][Full Text] [Related]
39. A Systematic Review of the Treatment of Superficial Leiomyosarcoma With Mohs Micrographic Surgery.
Murphy-Chutorian B; Routt E; Vinelli G; Ciocon D
Dermatol Surg; 2019 Dec; 45(12):1437-1441. PubMed ID: 31397774
[TBL] [Abstract][Full Text] [Related]
40. No Recurrence in Primary Invasive Stage 1a and 1b Melanoma and Melanoma in Situ Treated With Serial Disk Staged Excision.
Ahn GS; Pousti B; Singh G; Elsensohn A; Jiang SIB
Dermatol Surg; 2022 Mar; 48(3):276-282. PubMed ID: 34935746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
